Wendy Shelley

3.1k total citations · 1 hit paper
25 papers, 2.2k citations indexed

About

Wendy Shelley is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Wendy Shelley has authored 25 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cancer Research, 10 papers in Oncology and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Wendy Shelley's work include Breast Cancer Treatment Studies (10 papers), Breast Lesions and Carcinomas (7 papers) and Ovarian cancer diagnosis and treatment (6 papers). Wendy Shelley is often cited by papers focused on Breast Cancer Treatment Studies (10 papers), Breast Lesions and Carcinomas (7 papers) and Ovarian cancer diagnosis and treatment (6 papers). Wendy Shelley collaborates with scholars based in Canada, United States and New Zealand. Wendy Shelley's co-authors include Mark N. Levine, Francisco Perera, Jim A. Julian, Timothy J. Whelan, Jean‐Philippe Pignol, K Schneider, L. Grimard, Anthony Fyles, Carolyn Freeman and Himu Lukka and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Cancer.

In The Last Decade

Wendy Shelley

25 papers receiving 2.1k citations

Hit Papers

Long-Term Results of Hypofractionated Radiation Therapy f... 2010 2026 2015 2020 2010 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer
    2010 1.3k citations Timothy J. Whelan, Jean‐Philippe Pignol et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wendy Shelley Canada 19 1.3k 789 586 518 470 25 2.2k
Penny R. Anderson United States 26 1.2k 0.9× 675 0.9× 519 0.9× 559 1.1× 392 0.8× 87 2.4k
Herman Høst Norway 21 1.3k 1.0× 1.1k 1.3× 686 1.2× 312 0.6× 405 0.9× 66 2.5k
P. Romestaing France 32 1.1k 0.8× 1.8k 2.3× 582 1.0× 489 0.9× 426 0.9× 142 3.8k
B. Cutuli France 27 1.4k 1.1× 1.1k 1.4× 945 1.6× 142 0.3× 194 0.4× 91 2.9k
Marcella Del Vecchio Italy 14 2.3k 1.7× 1.2k 1.5× 1.3k 2.1× 216 0.4× 275 0.6× 18 3.1k
Himu Lukka Canada 24 1.3k 1.0× 1.1k 1.4× 517 0.9× 1.2k 2.3× 812 1.7× 77 4.4k
Robert H. Oishi United States 13 1.8k 1.3× 1.3k 1.7× 996 1.7× 152 0.3× 307 0.7× 15 3.0k
Vieri Scotti Italy 21 874 0.7× 764 1.0× 338 0.6× 382 0.7× 325 0.7× 109 1.6k
Maartje J. Hooning Netherlands 29 1.2k 0.9× 1.0k 1.3× 377 0.6× 221 0.4× 541 1.2× 73 3.0k
James P. Morden United Kingdom 17 658 0.5× 848 1.1× 152 0.3× 494 1.0× 375 0.8× 51 2.6k

Countries citing papers authored by Wendy Shelley

Since Specialization
Citations

This map shows the geographic impact of Wendy Shelley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wendy Shelley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wendy Shelley more than expected).

Fields of papers citing papers by Wendy Shelley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wendy Shelley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wendy Shelley. The network helps show where Wendy Shelley may publish in the future.

Co-authorship network of co-authors of Wendy Shelley

This figure shows the co-authorship network connecting the top 25 collaborators of Wendy Shelley. A scholar is included among the top collaborators of Wendy Shelley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wendy Shelley. Wendy Shelley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Whelan, Timothy J., Jean‐Philippe Pignol, Mark N. Levine, et al.. (2010). Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer. New England Journal of Medicine. 362(6). 513–520. 1260 indexed citations breakdown →
2.
Eisen, Andrea, Maureen Trudeau, Wendy Shelley, Hans Messersmith, & Kathleen I. Pritchard. (2008). Aromatase inhibitors in adjuvant therapy for hormone receptor positive breast cancer: A systematic review. Cancer Treatment Reviews. 34(2). 157–174. 65 indexed citations
3.
Whelan, Timothy J., Jean‐Philippe Pignol, Jim A. Julian, et al.. (2008). Long-term Results of a Randomized Trial of Accelerated Hypofractionated Whole Breast Irradiation Following Breast Conserving Surgery in Women with Node-Negative Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. 72(1). S28–S28. 22 indexed citations
4.
Shelley, Wendy, et al.. (2006). Management of Ductal Carcinoma in Situ of the Breast: A Clinical Practice Guideline. 3 indexed citations
5.
McCready, David R., et al.. (2005). Surgical management of early stage invasive breast cancer: a practice guideline.. PubMed. 48(3). 185–94. 72 indexed citations
6.
7.
Huang, Jenny, et al.. (2001). Risk of thyroid carcinoma in a female population after radiotherapy for breast carcinoma. Cancer. 92(6). 1411–1418. 39 indexed citations
8.
Shelley, Wendy, et al.. (2000). A shorter fractionation schedule for postlumpectomy breast cancer patients. International Journal of Radiation Oncology*Biology*Physics. 47(5). 1219–1228. 79 indexed citations
9.
Hayter, Charles, et al.. (2000). A prospective trial of short-course radiotherapy plus chemotherapy for palliation of dysphagia from advanced esophageal cancer. Radiotherapy and Oncology. 56(3). 329–333. 36 indexed citations
10.
Brundage, Michael, Peter F. Dixon, William J. Mackillop, et al.. (1999). A real-time audit of radiation therapy in a regional cancer center. International Journal of Radiation Oncology*Biology*Physics. 43(1). 115–124. 61 indexed citations
11.
Wong, Rebecca, et al.. (1998). In search of a dose-response relationship with radiotherapy in the management of recurrent rectal carcinoma in the pelvis: A systematic review. International Journal of Radiation Oncology*Biology*Physics. 40(2). 437–446. 24 indexed citations
12.
Crump, Michael, Carol Sawka, Gerrit DeBoer, et al.. (1997). An individual patient-based meta-analysis of tamoxifen versus ovarian ablation as first line endocrine therapy for premenopausal women with metastatic breast cancer. Breast Cancer Research and Treatment. 44(3). 201–210. 49 indexed citations
13.
Sawka, Carol, Kathleen I. Pritchard, Wendy Shelley, et al.. (1997). A randomized crossover trial of tamoxifen versus ovarian ablation for metastatic breast cancer in premenopausal women: A report of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) trial MA.1. Breast Cancer Research and Treatment. 44(3). 211–215. 30 indexed citations
14.
Monga, Manju, John A. Carmichael, Wendy Shelley, et al.. (1991). Surgery without adjuvant chemotherapy for early epithelial ovarian carcinoma after comprehensive surgical staging. Gynecologic Oncology. 43(3). 195–197. 39 indexed citations
15.
16.
Carmichael, John A., et al.. (1988). Advanced carcinoma of the ovary with central nervous system relapse. Gynecologic Oncology. 30(3). 398–406. 29 indexed citations
17.
Shelley, Wendy, Robert Fraser, Mary Ellen Kirk, et al.. (1988). Adriamycin and cisplatin in the treatment of stage III and IV epithelial ovarian carcinoma. Gynecologic Oncology. 29(2). 208–221. 17 indexed citations
18.
OʼConnell, G., Wendy Shelley, J. Carmichael, et al.. (1987). High-dose-intensity regimen of weekly doxorubicin and cisplatin in the treatment of patients with stage III and IV epithelial ovarian carcinoma.. PubMed. 71(5). 455–8. 3 indexed citations
19.
Carmichael, John A., Wendy Shelley, Robert Fraser, et al.. (1987). A predictive index of cure versus no cure in advanced ovarian carcinoma patients—Replacement of second-look laparotomy as a diagnostic test. Gynecologic Oncology. 27(3). 269–278. 26 indexed citations
20.
Sawka, C., Kathleen I. Pritchard, Alexander Paterson, et al.. (1986). Role and mechanism of action of tamoxifen in premenopausal women with metastatic breast carcinoma.. PubMed. 46(6). 3152–6. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Penny R. Anderson Breakdown of academic impact, for papers by Herman Høst Breakdown of academic impact, for papers by P. Romestaing Breakdown of academic impact, for papers by B. Cutuli Breakdown of academic impact, for papers by Marcella Del Vecchio Breakdown of academic impact, for papers by Himu Lukka Breakdown of academic impact, for papers by Robert H. Oishi Breakdown of academic impact, for papers by Vieri Scotti Breakdown of academic impact, for papers by Maartje J. Hooning Breakdown of academic impact, for papers by James P. Morden
Rankless by CCL
2026